The right signals can make or break an organoid model. From growth and differentiation to downstream drug testing, cytokines and growth factors are critical to creating cultures researchers can rely ...
A hybrid microrobotic platform combining living bacteria, nanoparticles and targeted chemotherapy has achieved 82.4 percent ...
Researchers at Nagoya University have identified BCAT1, an enzyme involved in proline supply for collagen synthesis, as a ...
PacBio and AI drug discovery company TychoBio are generating full-length RNA datasets from more than 10,000 samples to train ...
From self-driving laboratories to advanced cellular models, ELRIG Drug Discovery 2026 showcases technologies helping researchers generate better data, evaluate drug candidates and improve early ...
Cambridge biotech bit.bio has released ioAstrocytes 2.0, a genetically matched human astrocyte model designed to support ...
Poor recovery, inconsistent growth and changes in morphology can affect organoid research. How much experimental variability ...
The strongest disease signal may not point to the best drug target. AI could help researchers identify what matters within complex biological networks.
Dr Joseph Geraci is Co-Founder and Chief Scientific and Technical Officer at NetraMark, where he led the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results